67 related articles for article (PubMed ID: 2455930)
1. [The non-anticoagulant action of heparins: prospects].
Tobelem G
Rev Prat; 1988 May; 38(15):957-60. PubMed ID: 2455930
[No Abstract] [Full Text] [Related]
2. Molecular and cellular mechanisms of angiogenesis.
Maciag T
Important Adv Oncol; 1990; ():85-98. PubMed ID: 1691138
[No Abstract] [Full Text] [Related]
3. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
4. Non-anticoagulant effects of unfractionated and low-molecular weight heparins.
Walenga JM
Clin Adv Hematol Oncol; 2007 Oct; 5(10):759-60. PubMed ID: 17998892
[No Abstract] [Full Text] [Related]
5. Mast cells and tumour angiogenesis: the tumor-mediated release of an endothelial growth factor from mast cells.
Roche WR
Int J Cancer; 1985 Dec; 36(6):721-8. PubMed ID: 2415472
[TBL] [Abstract][Full Text] [Related]
6. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
Khorana AA; Sahni A; Altland OD; Francis CW
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2110-5. PubMed ID: 12920044
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell proliferation in vitro after incubation with anticoagulant and antiplatelet drugs.
Lindblad B; Wright SW; Burkel WE; Wakefield TW; Graham LM; Sell R; Stanley JC
Artery; 1988; 16(1):15-24. PubMed ID: 3144959
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of cell growth and inhibition of prostacyclin production by heparin in human umbilical vein endothelial cells.
Hasegawa N; Yamamoto M; Yamamoto K
J Cell Physiol; 1988 Dec; 137(3):603-7. PubMed ID: 3056961
[TBL] [Abstract][Full Text] [Related]
9. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures.
Bârzu T; Pascal M; Maman M; Roque C; Lafont F; Rousselet A
J Cell Physiol; 1996 Apr; 167(1):8-21. PubMed ID: 8698843
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of the endothelial cell.
Bicknell R
Behring Inst Mitt; 1993 Aug; (92):1-7. PubMed ID: 7504447
[No Abstract] [Full Text] [Related]
11. [From heparin to heparins: toward new therapeutic perspectives?].
Molho P; Tobelem G
Biomed Pharmacother; 1987; 41(4):171-5. PubMed ID: 3620582
[TBL] [Abstract][Full Text] [Related]
12. [Antiatherogenic action of heparin].
Stajszczyk M; Gmiński J
Postepy Hig Med Dosw; 1994; 48(3):275-90. PubMed ID: 7971602
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell-stimulating angiogenesis factor in vitreous from extraretinal neovascularizations.
Taylor CM; Kissun RD; Schor AM; McLeod D; Garner A; Weiss JB
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2174-8. PubMed ID: 2477343
[TBL] [Abstract][Full Text] [Related]
14. Cultured endothelium. Heparin antagonizes the induction of class II MHC molecules by interferon-gamma.
Korlipara LV; Pleass HC; Taylor RM; Proud G; Forsythe JL; Kirby JA
Transplantation; 1994 Dec; 58(12):1426-9. PubMed ID: 7809939
[No Abstract] [Full Text] [Related]
15. SR 25989 inhibits healing of a mechanical wound of confluent human saphenous vein endothelial cells which is modulated by standard heparin and growth factors.
Klein-Soyer C; Cazenave JP; Herbert JM; Maffrand JP
J Cell Physiol; 1994 Aug; 160(2):316-22. PubMed ID: 7518823
[TBL] [Abstract][Full Text] [Related]
16. The mode of action of anti-angiogenic steroid and heparin.
Harada I; Kikuchi T; Shimomura Y; Yamamoto M; Ohno H; Sato N
EXS; 1992; 61():445-8. PubMed ID: 1377569
[No Abstract] [Full Text] [Related]
17. Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF.
Wright TC; Johnstone TV; Castellot JJ; Karnovsky MJ
J Cell Physiol; 1985 Dec; 125(3):499-506. PubMed ID: 3877732
[TBL] [Abstract][Full Text] [Related]
18. Regulation of smooth muscle proliferation by heparin in vitro and in vivo.
Clowes AW; Clowes MM
Int Angiol; 1987; 6(1):45-51. PubMed ID: 3624946
[TBL] [Abstract][Full Text] [Related]
19. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
[TBL] [Abstract][Full Text] [Related]
20. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
